5,249
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Solely HBsAg intrauterine exposure accelerates HBV clearance by promoting HBs-specific immune response in the mouse pups

, , , , , , , , , , , ORCID Icon & show all
Pages 1356-1370 | Received 16 Nov 2021, Accepted 24 Apr 2022, Published online: 23 May 2022

References

  • Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403.
  • Chang MH. Natural history and clinical management of chronic hepatitis B virus infection in children. Hepatol Int. 2008;2(Supplement 1):28–36.
  • Milich DR, Jones JE, Hughes JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87(17):6599–6603.
  • Publicover J, Gaggar A, Nishimura S, et al. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013;123(9):3728–3739.
  • Publicover J, Goodsell A, Nishimura S, et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest. 2011;121(3):1154–1162.
  • Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int. 2013;33(Suppl 1):188–194.
  • Gentile I, Zappulo E, Buonomo AR, et al. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. Expert Rev Anti Infect Ther. 2014;12:775–782.
  • Tian Y, Kuo CF, Akbari O, et al. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44:1204–1214.
  • Burk RD, Hwang LY, Ho GY, et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis. 1994;170(6):1418–1423.
  • Chen Y, Wang L, Xu Y, et al. Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission. Microbes Infect. 2013;15:409–415.
  • Ma L, Alla NR, Li X, et al. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Rev Med Virol. 2014;24:396–406.
  • Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol. 1980;87(11):958–965.
  • Wei J, Xue S, Zhang J, et al. Study of the relationship in pregnant women between hepatitis B markers and a placenta positive for hepatitis B surface antigen. J Perinat Med. 2015;43(2):191–199.
  • Vyas AK, Ramakrishna U, Sen B, et al. Placental expression of asialoglycoprotein receptor associated with hepatitis B virus transmission from mother to child. Liver Int. 2018;38(12):2149–2158.
  • Tan J, Liu X, Mao X, et al. HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepat. 2016;23:812–819.
  • Wang J, He Y, Jin D, et al. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infect Dis (Lond). 2017;49(8):576–583.
  • Trehanpati N, Hissar S, Shrivastav S, et al. Immunological mechanisms of hepatitis B virus persistence in newborns. Indian J Med Res. 2013;138(5):700–710.
  • Kang G, Ma F, Chen H, et al. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers. Vaccine. 2015;33(33):4093–4099.
  • Hong M, Sandalova E, Low D, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588.
  • Chisari FV, Filippi P, McLachlan A, et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol. 1986;60(3):880–887.
  • Nicholson A, Reifsnyder PC, Malcolm RD, et al. Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene. Obesity. 2010;18:1902–1905.
  • Huang LR, Wu HL, Chen PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006;103(47):17862–17867.
  • Liu Y, Qi X, Zeng Z, et al. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Sci Rep. 2017;7(1):2796.
  • Kosinska AD, Pishraft-Sabet L, Wu W, et al. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models. Hepatology. 2017;66(1):69–83.
  • Maier H, Isogawa M, Freeman GJ, et al. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol. 2007;178(5):2714–2720.
  • McLane LM, Banerjee PP, Cosma GL, et al. Differential localization of T-bet and Eomes in CD8 T cell memory populations. J Immunol. 2013;190(7):3207–3215.
  • Miller CH, Klawon DEJ, Zeng S, et al. Eomes identifies thymic precursors of self-specific memory-phenotype CD8+ T cells. Nat Immunol. 2020;21(5):567–577.
  • McGovern N, Shin A, Low G, et al. Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2. Nature. 2017;546(7660):662–666.
  • Valladeau J, Duvert-Frances V, Pin JJ, et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol. 2001;167(10):5767–5774.
  • Untergasser A, Zedler U, Langenkamp A, et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology. 2006;43(3):539–547.
  • Maroof A, Beattie L, Kirby A, et al. Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen. J Immunol. 2009;183(11):7095–7103.
  • Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2009;106(21):8623–8628.
  • Urban S, Bartenschlager R, Kubitz R, et al. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology. 2014;147(1):48–64.
  • Cornberg M, Wong VW, Locarnini S, et al. The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 2017;66(2):398–411.
  • Cho JH, Kim HO, Kim KS, et al. Unique features of naive CD8+ T cell activation by IL-2. J Immunol. 2013;191(11):5559–5573.
  • Hervas-Stubbs S, Riezu-Boj J-I, Gonzalez I, et al. Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells. Eur J Immunol. 2010;40(12):3389–3402.
  • Huang S, Shen Y, Pham D, et al. IRF4 modulates CD8T cell sensitivity to IL-2 family cytokines. Immunohorizons. 2017;1(6):92–100.
  • Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 9th ed. Philadelphia (PA): Elsevier; 2018. p. 1–11.
  • Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368(6494):eaaz7548.
  • Balkow S, Kersten A, Tran TT, et al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol. 2001;75(18):8781–8791.
  • Schirmbeck R, Böhm W, Fissolo N, et al. Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur J Immunol. 2003;33(9):2429–2438.
  • Riedl P, Bertoletti A, Lopes R, et al. Distinct, cross-reactive epitope specificities of CD8T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes. J Immunol. 2006;176(7):4003–4011.
  • Gu X, Yang X, Wang D, et al. Comparison and significance of specific and non-specific cellular immunity in patients with chronic hepatitis B caused by infection with genotypes B or C of hepatitis B virus. Sci China C Life Sci. 2009;52(8):719–723.
  • Koumbi LJ, Papadopoulos NG, Anastassiadou V, et al. Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers. Clin Vaccine Immunol. 2010;17(7):1079–1085.
  • Sung CC, Horng JH, Siao SH, et al. Asialo GM1-positive liver-resident CD8T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus. Cell Mol Immunol. 2021;18(7):1772–1782.
  • McLane LM, Banerjee PP, Cosma GL, et al. Differential localization of T-bet and Eomes in CD8T cell memory populations. J Immunol. 2013;190(7):3207–3215.
  • Smith NL, Patel RK, Reynaldi A, et al. Developmental origin governs CD8T cell fate decisions during infection. Cell. 2018;174(1):117–130.e14.
  • Wang R, Chen K, Wang Y, et al. Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure. Vaccine. 2021;39(39):5571–5579.
  • Mayer KE, Mall S, Yusufi N, et al. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target. Theranostics. 2018;8(21):6070–6087.
  • Nance CL, Shearer WT. SDF-1alpha regulates HIV-1-gp120-induced changes in CD79b surface expression and Ig production in activated human B cells. Clin Immunol. 2002;105(2):208–214.
  • Kawabata KC, Ehata S, Komuro A, et al. TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20. Oncogene. 2013;32(16):2096–2106.
  • Li J, Yang HI, Yeh ML, et al. Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B. J Infect Dis. 2021;224(2):294–302.
  • Dilworth MR, Sibley CP. Review: transport across the placenta of mice and women. Placenta. 2013;34(Suppl):S34–S39.